Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GGT1 | P19440 | 1/20 | 0.46 |
| ▸ | NOS2 | P35228 | 5/20 | 0.43 |
| ▸ | ARG1 | P05089 | 1/20 | 0.42 |
| ▸ | ARG2 | P78540 | 1/20 | 0.42 |
| ▸ | BLM | P54132 | 2/20 | 0.41 |
| ▸ | NOS1 | P29475 | 3/20 | 0.40 |
| ▸ | TSHR | P16473 | 2/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.40 |
| ▸ | NOS3 | P29474 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.37 |
| ▸ | ADRA1A | P35348 | 2/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.37 |
| ▸ | MEN1 | O00255 | 2/20 | 0.37 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.37 |
| ▸ | USP2 | O75604 | 1/20 | 0.37 |
| ▸ | EGFR | P00533 | 1/20 | 0.37 |
| ▸ | FYN | P06241 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL161722 | 1.00 | GGT1 (0.46) | GGT1NOS2ARG1ARG2BLM | |
| SCHEMBL161723 | 1.00 | GGT1 (0.46) | GGT1NOS2ARG1ARG2BLM | |
| Asparagine SCHEMBL7046551 | 0.82 | GRIK1 (0.42) | GGT1BLMKMT2AALOX15PMP22 | |
| SCHEMBL28453562 | 0.81 | FDPS (0.33) | GGT1NOS2ARG1ARG2BLM | |
| SCHEMBL9823655 | 0.81 | FDPS (0.33) | GGT1NOS2ARG1ARG2BLM | |
| SCHEMBL28610049 | 0.81 | FDPS (0.33) | GGT1NOS2ARG1ARG2BLM | |
| SCHEMBL1875520 | 0.81 | TSHR (0.55) | GGT1NOS2ARG1ARG2BLM | |
| SCHEMBL162455 | 0.81 | TSHR (0.55) | GGT1NOS2ARG1ARG2BLM | |
| SCHEMBL1660876 | 0.81 | TSHR (0.55) | GGT1NOS2ARG1ARG2BLM | |
| SCHEMBL1986433 | 0.79 | GGT1 (0.46) | GGT1NOS2ARG1ARG2BLM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 150 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160318987-A1 | PROTEASE RESISTANT PEPTIDES | MEDIMMUNE LIMITED (GB) | 2016-11-03 | — | — | US | claimed |
| WO-2026107423-A1 | ORAL PEPTIDES AND USES THEREOF FOR WEIGHT LOSS, WEIGHT MAINTENANCE, AND MANAGEMENT OF METABOLIC CONDITIONS | METSERA, INC. (US) | 2026-05-21 | — | — | WO | disclosed |
| EP-4626479-A1 | COMPOSITIONS AND METHODS FOR PROTEIN INTERNALIZATION | Lytica Therapeutics, Inc. (US) | 2025-10-08 | — | — | EP | disclosed |
| US-20240201179-A1 | FLUOROGENIC SENSORS FOR DETECTING ANTIGENS | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2024-06-20 | — | — | US | disclosed |
| US-20240182532-A1 | MICROPEPTIDES AND USES THEREOF | FUNDACIÓ PRIVADA INSTITUT D'INVESTIGACIÓ ONCOLÒGICA DE VALL HEBRON (ES) | 2024-06-06 | — | — | US | disclosed |
| WO-2024119049-A1 | COMPOSITIONS AND METHODS FOR PROTEIN INTERNALIZATION | LYTICA THERAPEUTICS, INC. (US) | 2024-06-06 | — | — | WO | disclosed |
| US-20240174723-A1 | STAPLED ANTIMICROBIAL PEPTIDES (STAMPS) AND USES THEREOF | LYTICA THERAPEUTICS, INC. (US) | 2024-05-30 | — | — | US | disclosed |
| US-20240124525-A1 | PROLINE-LOCKED STAPLED PEPTIDES AND USES THEREOF | PRESIDENT AND FELLOWS OF HARVARD COLLEGE | 2024-04-18 | — | — | US | disclosed |
| EP-4351656-A1 | PEPTIDES COMPRISING N-FORMYL-HALOGENATED METHIONINE RESIDUES AND ENGINEERED ANTIBODY-PEPTIDE CONJUGATES THEREOF | Eli Lilly and Company (US) | 2024-04-17 | — | — | EP | disclosed |
| CN-117750981-A | Peptides comprising N-formyl-halomethionine residues and engineered antibody-peptide conjugates thereof | 伊莱利利公司 | 2024-03-22 | — | — | CN | disclosed |
| WO-2011002955-A2 | METHODS FOR MAKING EMBRYONIC CELLS, EMBRYOS, AND ANIMALS SENSITIZED TO STRESS | BRANDEIS UNIVERSITY (US) | 2011-01-06 | — | — | WO | disclosed |
| US-20100184645-A1 | STITCHED POLYPEPTIDES | PRESIDENT AND FELLOWS OF HARVARD COLLEGE | 2010-07-22 | — | — | US | disclosed |
| WO-2010025510-A1 | LIBRARIES OF PEPTIDE CONJUGATES AND METHODS FOR MAKING THEM | XENOME LTD (AU) | 2010-03-11 | — | — | WO | disclosed |
| EP-1261360-B1 | CASEIN DERIVED PEPTIDES AND USES THEREOF IN THERAPY | PEPTERA PHARMACEUTICALS LTD (IL) | 2009-12-16 | — | — | EP | disclosed |
| EP-1033999-A4 | COMPOSITIONS OF LEUKAEMIA INHIBITORY FACTOR | AMRAD OPERATIONS PTY LTD (AU) | 2004-11-03 | — | — | EP | disclosed |
| CN-1351663-A | Viral variants | NORTH WESTER HEALTH CARE NETWO (AU) | 2002-05-29 | — | — | CN | disclosed |
| EP-1033999-A1 | COMPOSITIONS OF LEUKAEMIA INHIBITORY FACTOR | Amrad Operations Pty.,Ltd. (AU) | 2000-09-13 | — | — | EP | disclosed |
| WO-1999027950-A1 | COMPOSITIONS OF LEUKAEMIA INHIBITORY FACTOR | AMRAD OPERATIONS PTY. LTD. (AU) | 1999-06-10 | — | — | WO | disclosed |
| WO-1999014243-A1 | IMMUNOINTERACTIVE MOLECULES AND USES THEREFOR | CONE ROBERT EDWARD (US) | 1999-03-25 | — | — | WO | disclosed |
| WO-1998048011-A1 | NOVEL CHIMERIC MOLECULES | THE WALTER AND ELIZA HALL INSTITUTE OF MEDICAL RESEARCH (AU) | 1998-10-29 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240201179-A1 | FLUOROGENIC SENSORS FOR DETECTING ANTIGENS | CD2BP2, CD69, LY96 | GGT1 983/4885NOS2 3284/4885ARG1 4504/4885 |
| US-20100184645-A1 | STITCHED POLYPEPTIDES | VIP, IAPP, NGLY1 | GGT1 1030/4885NOS2 3723/4885ARG1 3301/4885 |
| US-20240124525-A1 | PROLINE-LOCKED STAPLED PEPTIDES AND USES THEREOF | PRAP1, PRR12, NPPA | GGT1 1272/4885NOS2 2179/4885ARG1 1137/4885 |
| US-20240174723-A1 | STAPLED ANTIMICROBIAL PEPTIDES (STAMPS) AND USES THEREOF | NGLY1, MDN1, SPPL2B | GGT1 2173/4885NOS2 2013/4885ARG1 245/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.